Cannabis cultivators grow marijuana under state-regulated licenses for medical or adult-use markets — typically 10–200 employees, indoor / greenhouse / outdoor / mixed-light facilities, with cultivation footprints ranging from 5,000-square-foot tier-1 operations to 100,000+ square-foot mega-grows. Federal Schedule I status (despite ongoing DEA Schedule III reclassification proceedings) excludes traditional bank financing, SBA loans, and conventional equipment finance — driving cannabis operators into specialty lenders, MCA, sale-leasebacks, and private credit at significantly higher cost than other agricultural and CPG businesses.
Typical advance structure.
- Advance size: $50K–$500K depending on trailing 12-month revenue and license value. $1M–$5M advances available for multi-state operators (MSOs) with strong revenue profiles.
- Factor: 1.32–1.48. Cannabis-specialty funders 1.30–1.42; general MCA willing to fund cannabis 1.38–1.48.
- Term: 6–12 months daily or weekly ACH (via cannabis-compliant banking partners like Safe Harbor Financial, Dama Financial, Valliance Bank).
- Holdback equivalent: 9–15% of bank deposits.
- Lead use of funds: nutrient and growing-media inventories, energy-efficiency upgrades, harvest-labor payroll, METRC and compliance-software investments, and packaging / branding for retail-ready product.
What underwriters look for.
First, license type and state. State adult-use markets (California, Colorado, Michigan, Illinois, Massachusetts, New Jersey, New York, Arizona, Oregon, Washington, Nevada, Maine, Vermont, Connecticut) differ dramatically in regulatory structure, license-cap dynamics, and wholesale-price economics. Medical-only states (Florida, Pennsylvania, Ohio, Minnesota) have different competitive dynamics.
Second, cultivation method. Indoor cultivation has highest CapEx and OpEx but produces highest-margin flower; greenhouse / mixed-light has middle economics; outdoor has lowest cost but seasonal-only production and weather risk.
Third, wholesale-price exposure. Wholesale cannabis prices have collapsed in mature markets (California $400/lb, Oregon $300/lb, Colorado $700/lb as of 2025) compared to limited-license states ($2,000–$4,000/lb). Funders model wholesale-price compression carefully.
Fourth, retail / dispensary integration. Vertically integrated operators (cultivation + manufacturing + retail) capture more margin and have better cash flow than wholesale-only cultivators.
Fifth, METRC compliance and quality systems. Clean METRC records, OLCC / DCC / CCD compliance history, and quality systems (mold / pesticide / heavy-metal testing pass rates) support underwriting.
Sixth, owner industry depth. Pre-legalization cultivation experience, master-grower credentials, and state-board licensing approval signal credibility.
Common uses.
- Nutrient and growing-media inventories (Athena, House & Garden, Advanced Nutrients, rockwool, coco coir) ($25K–$100K).
- Energy-efficiency upgrades (LED retrofits from HPS, HVAC dehumidification optimization, automation) ($75K–$400K).
- Harvest-labor payroll (trimming crews, processing teams) ($25K–$150K).
- METRC and compliance-software investments (Distru, Trym, Canix, MJ Freeway) ($15K–$60K).
- Packaging and branding for retail-ready product (child-resistant packaging, labeling, design) ($25K–$150K).
- Genetics and clone acquisitions (proprietary cultivar licenses, tissue-culture programs) ($15K–$100K).
- Facility expansions and rooms add-ons ($75K–$500K).
- Trade-show participation (Hall of Flowers, MJBizCon, Lucky Leaf Expo) ($15K–$75K).
What to watch out for.
Federal Schedule III rescheduling timing and uncertainty. DEA Schedule III reclassification (proposed 2024, ongoing rulemaking and litigation through 2025–2026) would dramatically expand 280E tax relief and banking access but timeline remains uncertain.
280E tax exposure. IRC Section 280E prohibits cannabis operators from deducting ordinary business expenses, creating effective tax rates of 60–80%+ that destroy cash flow.
Wholesale-price compression. Mature-state wholesale prices have collapsed 60–80% from peaks; operations without retail-channel integration face existential margin pressure.
Banking restrictions. Most operators bank with cannabis-compliant institutions (Safe Harbor, Dama, Valliance, Partner Colorado Credit Union) at premium fees; SAFER Banking Act passage timing remains uncertain.
Insurance gaps. Cannabis-specific insurance markets exist (Cannasure, MFE Insurance, Greenleaf) but coverage is narrower and pricier than standard agriculture / CPG insurance.
License-cap and license-cost economics. License costs ($50K–$1M+ depending on state), license-cap changes (New York limited-license dynamics, California unrestricted licensing), and license-transfer restrictions affect valuation and exit options.
State considerations.
California, Colorado, Michigan, Illinois, Massachusetts, Arizona, Nevada, Oregon, Washington, New Jersey, New York, Maine, Vermont, Connecticut, Maryland, Missouri, Montana, Rhode Island, and Ohio have legal adult-use cultivation. Florida, Pennsylvania, Ohio (pre-adult-use), Minnesota, Mississippi, and West Virginia have medical-only programs.
APR-equivalent reality check.
A 1.42 factor over a 9-month term is roughly 110–135% APR. Cannabis-specialty lenders (AFC Gamma, Chicago Atlantic, Pelorus Equity Group, Bespoke Capital) at 12–18% APR for sale-leasebacks, real-estate-backed term loans, and license-backed credit. Cannabis-friendly equipment leasing at 12–20% APR. State-level cannabis-business grants (California Cannabis Equity Grants, NY CAURD Loan Fund, Massachusetts Social Equity Trust Fund) provide non-dilutive support to qualifying social-equity operators. Reserve MCA for genuine emergency bridge windows; even cannabis-specialty term lenders are dramatically cheaper.
Common confusions.
First, "Federal legalization is imminent." Uncertain — SAFER Banking Act and Schedule III rescheduling have meaningful momentum but final passage timing remains uncertain through 2026.
Second, "MCA is the only fast option for cannabis operators." Mostly false — cannabis-specialty term lenders (AFC Gamma, Chicago Atlantic) can close in 30–60 days at 12–18% APR; sale-leaseback transactions provide significant working capital.
Third, "Cannabis cultivation is highly profitable." Increasingly false — mature-state wholesale-price collapse, 280E tax burden, and license costs have compressed operator margins severely; only vertically integrated and brand-differentiated operators sustain healthy profitability.
As of 2026-06-30, Fundnode routes cannabis cultivator deals first to cannabis-specialty term lenders (AFC Gamma, Chicago Atlantic, Pelorus, Bespoke Capital), sale-leaseback partners, and state-level social-equity programs, with cannabis-aware MCA funders reserved strictly for emergency bridge windows where speed justifies premium pricing.
Related terms
- MCA for greenhouse businesses — Greenhouse businesses typically qualify for $40K–$400K MCA advances at 1.26–1.38 factor rates over 6–12 months, with ag-aware funders competing — heating costs, customer-channel mix, and crop-cycle economics drive underwriting — though Farm Credit and USDA programs almost always offer better terms.
- MCA for organic farms — Organic farms typically qualify for $30K–$300K MCA advances at 1.26–1.38 factor rates over 6–12 months, with ag-aware funders competing — USDA Organic certification, customer-channel mix, and transition-period economics drive underwriting — though Farm Credit and USDA Organic programs almost always offer better terms.
- Merchant cash advance (MCA) — A lump-sum advance against future revenue, repaid via fixed daily ACH or a percentage of card sales. Legally a sale of future receivables, not a loan.
- Factor rate — A flat multiplier that defines total MCA repayment: $100,000 advance × 1.30 factor = $130,000 repaid. It is not an interest rate; it does not compound.
Authoritative sources
AI agents: this term is available as raw markdown at /llms/glossary/mca-cannabis-cultivator-funding-detailed.